206 related articles for article (PubMed ID: 19069677)
1. Relationship between familial combined hyperlipidemia and insulin resistance.
Jackuliaková D; Vaverková H; Karásek D
Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
[TBL] [Abstract][Full Text] [Related]
2. Brachial endothelial function in subjects with familial combined hyperlipidemia and its relationships to carotid artery intima-media thickness.
Karásek D; Vaverková H; Halenka M; Budíková M; Novoty D
Int Angiol; 2006 Dec; 25(4):418-26. PubMed ID: 17164751
[TBL] [Abstract][Full Text] [Related]
3. Role of insulin resistance in familial combined hyperlipidemia.
Veerkamp MJ; de Graaf J; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
[TBL] [Abstract][Full Text] [Related]
4. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
5. Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease.
Cicero AF; Derosa G; Manca M; Bove M; Borghi C; Gaddi AV
Endothelium; 2007; 14(4-5):193-8. PubMed ID: 17922335
[TBL] [Abstract][Full Text] [Related]
6. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
Castro Cabezas M; de Bruin TW; de Valk HW; Shoulders CC; Jansen H; Willem Erkelens D
J Clin Invest; 1993 Jul; 92(1):160-8. PubMed ID: 8100834
[TBL] [Abstract][Full Text] [Related]
7. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
[TBL] [Abstract][Full Text] [Related]
8. Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia.
Mateo-Gallego R; Calmarza P; Jarauta E; Burillo E; Cenarro A; Civeira F
Metabolism; 2010 Feb; 59(2):154-8. PubMed ID: 19913843
[TBL] [Abstract][Full Text] [Related]
9. Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives.
Bredie SJ; Tack CJ; Smits P; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1465-71. PubMed ID: 9261281
[TBL] [Abstract][Full Text] [Related]
10. [The metabolic syndrome, its heredity, methods of detection and clinical significance].
Válek J; Vlasáková Z
Vnitr Lek; 1997 Sep; 43(9):566-73. PubMed ID: 9750464
[TBL] [Abstract][Full Text] [Related]
11. [Endothelial dysfunction in a family with familial combined hyperlipidemia].
Karásek D; Vaverková H; Hutyra M; Halenka M; Novotnyý D; Budíková M; Slavík L
Vnitr Lek; 2003 Aug; 49(8):623-9. PubMed ID: 14518086
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia.
de Graaf J; van der Vleuten G; Stalenhoef AF
Semin Vasc Med; 2004 Aug; 4(3):229-40. PubMed ID: 15630632
[TBL] [Abstract][Full Text] [Related]
13. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
[TBL] [Abstract][Full Text] [Related]
14. Impact of obesity in primary hyperlipidemias.
Carmena R; Ascaso JF; Real JT
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha is a marker of familial combined hyperlipidemia, independently of metabolic syndrome.
Pauciullo P; Gentile M; Marotta G; Baiano A; Ubaldi S; Jossa F; Iannuzzo G; Faccenda F; Panico S; Rubba P
Metabolism; 2008 Apr; 57(4):563-8. PubMed ID: 18328361
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome.
Khan SH; Khan FA; Ijaz A; Sattar A; Dilawar M; Hashim R
J Ayub Med Coll Abbottabad; 2008; 20(3):17-22. PubMed ID: 19610507
[TBL] [Abstract][Full Text] [Related]
17. Endothelial function in familial combined hyperlipidaemia.
Ter Avest E; Holewijn S; van Tits LJ; de Wit HM; Stalenhoef AF; de Graaf J
Eur J Clin Invest; 2007 May; 37(5):381-9. PubMed ID: 17461984
[TBL] [Abstract][Full Text] [Related]
18. [Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents].
Ribalta J; La Ville AE; Heras M; Plana N; Masana L
Med Clin (Barc); 1997 Jun; 109(5):161-4. PubMed ID: 9289537
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance phenotypes and coronary artery disease in a native Pakistani cohort.
Wierzbicki AS; Nishtar S; Lumb PJ; Lambert-Hammill M; Crook MA; Marber MS; Gill J
Int J Clin Pract; 2008 May; 62(5):701-7. PubMed ID: 18341566
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.
Allayee H; Castellani LW; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2003 Jun; 92(11):1262-7. PubMed ID: 12738753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
